Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)
●International Lymphoma Radiation Oncology Group (ILROG): Guidelines for the optimal use of imaging in radiation therapy for lymphoma (2019)
●Revised adult T-cell leukemia-lymphoma international consensus meeting report (2019)
●ILROG: Guidelines on lymphoblastic lymphoma (2018)
●ILROG: Field and dose guidelines for modern radiation therapy for extranodal lymphomas (2015)
●European Organisation for Research and Treatment of Cancer (EORTC), International Society for Cutaneous Lymphomas (ISCL), and United States Cutaneous Lymphoma Consortium (USCLC): Consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders – Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma (2011)
Canada
●Choosing Wisely Canada: Don't request a fine-needle aspirate (FNA) for the evaluation of suspected lymphoma (updated 2023)
●Cancer Care Ontario (CCO): The clinical utility of positron emission tomography in the diagnosis, staging, and clinical management of patients with lymphoma – Recommendation report (2015)
United States
●National Cancer Institute (NCI): Peripheral T-cell non-Hodgkin lymphoma treatment (PDQ) – Health professional version (updated 2023)
●American Society for Clinical Pathology (ASCP) and College of American Pathologists (CAP): Guideline for the laboratory workup of lymphoma in adults (2021)
●American Registry of Pathology (ARP): Expert opinions – Recommendations for the diagnostic workup of mature T cell neoplasms (2020)
●European Organisation for Research and Treatment of Cancer (EORTC), International Society for Cutaneous Lymphomas (ISCL), and United States Cutaneous Lymphoma Consortium (USCLC): Consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders – Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma (2011)
Europe
●European Society for Medical Oncology (ESMO): Consensus conference on malignant lymphoma – General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma (2018)
●ESMO: Clinical practice guidelines for diagnosis, treatment and follow-up of peripheral T-cell lymphomas (2015)
●European Organisation for Research and Treatment of Cancer (EORTC), International Society for Cutaneous Lymphomas (ISCL), and United States Cutaneous Lymphoma Consortium (USCLC): Consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders – Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma (2011)
United Kingdom
●British Society for Haematology (BSH): Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma) (2022)
●National Cancer Research Institute (NCRI): Recommendations for radiotherapy technique and dose in extra-nodal lymphoma (2016)
●National Institute for Health and Care Excellence (NICE): Guideline on non-Hodgkin's lymphoma – Diagnosis and management (2016)
India
●Indian Council of Medical Research (ICMR): Consensus document for management of non Hodgkin's lymphoma (high grade) (2016)
Australia–New Zealand
●Choosing Wisely Australia: Limit surveillance computed tomography (CT) scans in asymptomatic patients with confirmed complete remission following curative intent treatment for aggressive lymphoma – except for patients on a clinical trial (2015)
Japan
●[In Japanese] Japanese Society of Hematology (JSH): Hematopoietic tumor clinical practice guidelines, 3rd edition (2023)
●[In English] JSH: Practical guidelines for hematological malignancies, 2018 – Adult T-cell leukemia–lymphoma (published 2019)
●[In English] JSH: Practical guidelines for hematological malignancies, 2018 – Extranodal NK/T-cell lymphoma, nasal type (ENKL) (published 2019)
●[In English] JSH: Practical guidelines for hematological malignancies, 2018 – Peripheral T-cell lymphoma (PTCL) (published 2019)
